Publications

Browse our publications catalogue to learn about our research.

Developing a 3D bone model of osteosarcoma to investigate cancer mechanisms and evaluate treatments

Hannah L. Smith, Stephen A. Beers, Janos M. Kanczler & Juliet C. Gray, 2024, The FASEB Journal, 38(24)

DOI: 10.1096/fj.202402011R

Type: article

Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations

Jane Willoughby, Lang Dou, Sabyasachi Bhattacharya & Mark Cragg, 2024, Journal for Immunotherapy of Cancer, 12(7)

DOI: 10.1136/jitc-2023-008677

Type: article

Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc

Osman Dadas, Joel D. Allen, Sarah L. Buchan, Jinny H. Kim, H.T. Claude Chan, C. Ian Mockridge, Patrick J. Duriez, Anne Rogel, Max Crispin & Aymen Al-Shamkhani, 2023, Frontiers in Immunology, 14

DOI: 10.3389/fimmu.2023.1252274

Type: article

Predicting 天发娱乐棋牌_天发娱乐APP-官网|下载 infection risk in people who are immunocompromised by antibody testing

Ratna Wijaya, Marina Johnson, Nicola Campbell, Beth Stuart, Adam Kelly, Nicole Tipler, Tobias Menne, Matthew J. Ahearne, Victoria Willimott, Anna Bowzyk Al-Naeeb, Christopher P. Fox, Graham P. Fox, Graham P. Collins, Ann O'Callaghan, Andrew J. Davies, David Goldblatt & Sean H. Lim, 2023, The Lancet, 402(10396), 99-102

DOI: 10.1016/S0140-6736(23)01180-7

Type: letterEditorial

Fc-γ receptor-mediated crosslinking co-defines the immunostimulatory activity of anti-human CD96 antibodies

Anne Rogel, Fathima M Ibrahim, Stephen Thirdborough, Florence Renart-Depontieu, Charles Birts, Sarah Buchan, Xavier Preville, Emma King & Aymen Al-Shamkhani, 2022, JCI Insight, 7(19)

DOI: 10.1172/jci.insight.158444

Type: article